Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Ex-vivo assessment and non-invasive in vivo imaging of internal hemorrhages in Aga2/+ mutant mice.
Biochem. Biophys. Res. Commun. 432, 389-393 (2013)
Mutations in type I collagen genes (COL1A1/2) typically lead to Osteogenesis imperfecta, the most common heritable cause of skeletal fractures and bone deformation in humans. Heterozygous Col1a1, animals with a dominant mutation in the terminal C-propeptide domain of type I collagen develop typical skeletal hallmarks and internal hemorrhages starting from 6day after birth. The disease progression for Aga2/+ mice, however, is not uniform differing between severe phenotype lethal at the 6-11th day of life, and moderate-to-severe one with survival to adulthood. Herein we investigated whether a new modality that combines X-ray computer tomography with fluorescence tomography in one hybrid system can be employed to study internal bleedings in relation to bone fractures and obtain insights into disease progression. The disease phenotype was characterized on Aga2/+ vs. wild type mice between 6 and 9days postnatal. Anatomical and functional findings obtained in-vivo were contrasted to the ex-vivo appearance of the same tissues under cryo-slicing.
Impact Factor
Scopus SNIP
Altmetric
2.406
0.758
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Osteogenesis Imperfecta ; Hemorrhages ; Fluorescence Molecular Tomography ; X-ray Computer Tomography ; Vascular Contrast Agent ; Collagen Mutation; Ray Computed-tomography ; Osteogenesis-imperfecta ; Fluorescence ; Diathesis ; Trauma ; System
Sprache
englisch
Veröffentlichungsjahr
2013
HGF-Berichtsjahr
2013
ISSN (print) / ISBN
0006-291X
e-ISSN
1090-2104
Quellenangaben
Band: 432,
Heft: 2,
Seiten: 389-393
Verlag
Elsevier
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Biological and Medical Imaging (IBMI)
Institute of Experimental Genetics (IEG)
Institute of Experimental Genetics (IEG)
POF Topic(s)
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
30201 - Metabolic Health
Forschungsfeld(er)
Enabling and Novel Technologies
Genetics and Epidemiology
Genetics and Epidemiology
PSP-Element(e)
G-505500-001
G-500600-003
G-500600-003
PubMed ID
23333738
WOS ID
WOS:000316438700032
Scopus ID
84875244678
Erfassungsdatum
2013-03-13